N4 Pharma (N4P) Competitors

GBX 0.80
0.00 (0.00%)
(As of 05/3/2024 ET)

N4P vs. HELD, EVG, DEMG, PYC, IDHC, NFX, APTA, IQAI, FAB, and TRLS

Should you be buying N4 Pharma stock or one of its competitors? The main competitors of N4 Pharma include Hellenic Dynamics (HELD), Evgen Pharma (EVG), Deltex Medical Group (DEMG), Physiomics (PYC), Integrated Diagnostics (IDHC), Nuformix (NFX), Aptamer Group (APTA), IQ-AI (IQAI), Fusion Antibodies (FAB), and Trellus Health (TRLS). These companies are all part of the "medical" sector.

N4 Pharma vs.

Hellenic Dynamics (LON:HELD) and N4 Pharma (LON:N4P) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, community ranking, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

N4 Pharma received 103 more outperform votes than Hellenic Dynamics when rated by MarketBeat users.

CompanyUnderperformOutperform
Hellenic DynamicsN/AN/A
N4 PharmaOutperform Votes
103
65.61%
Underperform Votes
54
34.39%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hellenic Dynamics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
N4 Pharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

0.1% of Hellenic Dynamics shares are held by institutional investors. 72.9% of Hellenic Dynamics shares are held by insiders. Comparatively, 22.3% of N4 Pharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Hellenic Dynamics has higher earnings, but lower revenue than N4 Pharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hellenic DynamicsN/AN/AN/AN/AN/A
N4 Pharma£23.52K91.41-£1.27M-£0.01-80.00

N4 Pharma's return on equity of 0.00% beat Hellenic Dynamics' return on equity.

Company Net Margins Return on Equity Return on Assets
Hellenic DynamicsN/A N/A N/A
N4 Pharma N/A -77.81%-51.74%

In the previous week, Hellenic Dynamics' average media sentiment score of 0.87 beat N4 Pharma's score of 0.00 indicating that N4 Pharma is being referred to more favorably in the news media.

Company Overall Sentiment
Hellenic Dynamics Neutral
N4 Pharma Positive

Summary

Hellenic Dynamics beats N4 Pharma on 4 of the 7 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding N4P and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

N4P vs. The Competition

MetricN4 PharmaDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£2.15M£1.15B£5.00B£1.71B
Dividend Yield3.12%3.01%2.89%5.94%
P/E Ratio-80.001,205.51151.442,091.29
Price / Sales91.4110,285.632,441.04449,924.60
Price / Cash2.2510.2449.7337.29
Price / BookN/A3.594.882.49
Net Income-£1.27M£118.14M£103.85M£181.87M
7 Day Performance3.23%2.51%3.93%0.99%
1 Month Performance10.34%-0.95%-3.04%7.91%
1 Year Performance-57.10%23.67%4.24%14.85%

N4 Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HELD
Hellenic Dynamics
0 of 5 stars
GBX 2.80
+9.8%
N/AN/A£3.53MN/A0.00N/A
EVG
Evgen Pharma
0 of 5 stars
GBX 0.80
flat
N/A-78.9%£2.20MN/A-80.0010
DEMG
Deltex Medical Group
0 of 5 stars
GBX 0.13
+8.3%
N/A-92.1%£2.47M£2.38M-5.7544Gap Up
PYC
Physiomics
0 of 5 stars
GBX 1.55
+14.8%
N/A-54.9%£2.10M£900,707.00-13.8310News Coverage
High Trading Volume
IDHC
Integrated Diagnostics
0 of 5 stars
GBX 0.35
flat
N/A-30.3%£2.07M£4.12B17.256,718
NFX
Nuformix
0 of 5 stars
GBX 0.21
flat
N/A-21.2%£1.68M£50,000.00-1.633
APTA
Aptamer Group
0 of 5 stars
GBX 0.73
+7.4%
N/A-97.6%£3.39M£1.03M-9.0637High Trading Volume
IQAI
IQ-AI
0 of 5 stars
GBX 1.55
+3.3%
N/A-42.9%£3.44M£538,190.00-13.676
FAB
Fusion Antibodies
0 of 5 stars
GBX 3.80
flat
N/A-92.0%£3.62M£1.58M-42.2248News Coverage
TRLS
Trellus Health
0 of 5 stars
GBX 2.25
+12.5%
N/A-72.2%£3.63M£35,000.00225.0031Gap Up
High Trading Volume

Related Companies and Tools

This page (LON:N4P) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners